Advanced Mental Health Treatments Beyond Traditional Therapy
At TMS of Westchester, we are committed to offering the most comprehensive and innovative mental health treatment options available. In addition to our signature TMS Therapy and MeRT programs, we provide a full suite of additional cutting-edge treatments to help patients in Mt Kisco, NY achieve lasting relief. Call (914) 241-0758 to learn which options are right for you.
Our Full Range of Treatment Options
The mental health landscape has evolved dramatically in recent years, and TMS of Westchester is at the forefront of that evolution. Our practice offers a comprehensive array of advanced therapies — many of which are not widely available at other psychiatric practices — allowing us to serve even the most complex and treatment-resistant cases.
TMS Therapy
Transcranial Magnetic Stimulation (TMS) is the foundation of our practice. FDA-cleared for major depressive disorder and OCD, TMS uses precisely targeted magnetic pulses to stimulate underperforming areas of the brain. It is non-invasive, drug-free, and has been shown to produce significant symptom relief in patients who have not responded to antidepressant medications. We have delivered over 20,000 TMS treatments with an 80% significant improvement rate. Learn more on our TMS Therapy page.
MeRT (Magnetic e-Resonance Therapy)
MeRT is our most personalized neuromodulation offering. By combining rTMS with qEEG and EKG data, we develop a fully individualized brain treatment protocol based on each patient’s unique neural signature. MeRT is particularly effective for conditions including PTSD, depression, autism spectrum disorder, and traumatic brain injury. We treat patients of all ages, including children as young as 3. Learn more on our MeRT page.
Accelerated TMS and One-D TMS
For patients who need faster results or cannot commit to a multi-week daily schedule, we offer Accelerated TMS — the FDA-approved SAINT protocol that delivers a full course of TMS in just five days — and One-D TMS, our revolutionary single-day treatment protocol for treatment-resistant depression.
Genetic Testing
Pharmacogenomic (genetic) testing allows our clinical team to analyze how your individual genetic makeup affects your response to psychiatric medications. By understanding which medications your body is most likely to metabolize effectively — and which to avoid — we can make more informed, personalized prescribing decisions from the outset. This reduces the trial-and-error process that many patients experience when starting psychiatric medication and improves the likelihood of finding the right medication faster. Genetic testing is a powerful tool that can be especially valuable when used alongside our Medication Management services.
Spravato (Esketamine)
Spravato (esketamine) is an FDA-approved nasal spray treatment for treatment-resistant depression and major depressive disorder with suicidal ideation. Administered in a monitored clinical setting, Spravato works rapidly — often producing noticeable improvements within hours to days — by targeting the NMDA receptor system in the brain, a mechanism entirely different from traditional antidepressants. At TMS of Westchester, Spravato treatments are conducted under careful clinical supervision in our Mt Kisco office, with patients resting for approximately two hours post-treatment before being cleared to leave. Spravato may be covered by insurance for qualifying patients.
Spravato can be particularly valuable for patients with severe, longstanding depression who have not responded to multiple antidepressant trials, or for those in acute need of rapid symptom relief. It can also be combined with other treatments — including TMS Therapy and psychotherapy — as part of a comprehensive care plan.
A Comprehensive, Integrative Approach to Mental Health
At TMS of Westchester, we believe that no single treatment is right for every patient. Our ability to offer such a wide range of advanced therapies — from FDA-cleared TMS and esketamine to personalized MeRT and genetic testing — gives us the flexibility to match every patient with the approach or combination of approaches that best fits their individual needs, history, and goals.
Whether you are dealing with anxiety, bipolar disorder, OCD, ADHD, treatment-resistant depression, or chronic pain, our team has the expertise and the tools to help. Contact us at (914) 241-0758 or visit our New Patients page to get started with a comprehensive evaluation in Mt Kisco, NY.
Frequently Asked Questions — Additional Treatments
What is Spravato (esketamine) and how does it differ from ketamine?
Spravato (esketamine) is an FDA-approved nasal spray that is a derivative of ketamine, specifically formulated for use in treatment-resistant depression and major depressive disorder with suicidal ideation. Unlike intravenous ketamine infusions offered at some clinics, Spravato is the only FDA-approved ketamine-based treatment administered in a certified healthcare setting under physician supervision. At TMS of Westchester, all Spravato treatments are conducted with careful clinical oversight to ensure your safety and comfort.
What is pharmacogenomic (genetic) testing and why is it useful in psychiatric care?
Pharmacogenomic testing analyzes your genetic profile to determine how your body processes and responds to specific psychiatric medications. This helps our team at TMS of Westchester make more informed prescribing decisions, reduce the trial-and-error process of finding the right antidepressant or other medication, and minimize the risk of adverse reactions. It is particularly helpful when used in conjunction with our Medication Management program.
Can Spravato be combined with TMS Therapy?
Yes. Spravato and TMS Therapy can be used as part of a combined treatment strategy for patients with severe or treatment-resistant depression. Our team will evaluate your clinical history and determine whether a combination approach is appropriate and safe for your specific situation.
How quickly does Spravato work?
Spravato acts through a different mechanism than traditional antidepressants, targeting the NMDA receptor system rather than serotonin or dopamine pathways. This can produce notably faster results — some patients experience improvement in depressive symptoms within hours to days of their first treatment, rather than the weeks typically required for conventional antidepressants to take effect.
Is Spravato covered by insurance?
Spravato may be covered by insurance for qualifying patients diagnosed with treatment-resistant depression or major depressive disorder with suicidal ideation. Coverage varies by plan. Our team at TMS of Westchester will help you understand your insurance options and navigate the authorization process. Call (914) 241-0758 for more information.
Does TMS of Westchester offer any treatments specifically for treatment-resistant cases?
Yes — in fact, many of our most advanced offerings are specifically designed for treatment-resistant patients. These include TMS Therapy, Accelerated TMS (SAINT protocol), One-D TMS, MeRT, and Spravato. Our team specializes in helping patients who have not found relief through conventional approaches.
How do I know which treatment is right for me?
The best way to determine which treatment or combination of treatments is right for you is to schedule a comprehensive evaluation with our team at TMS of Westchester. We will review your full medical and psychiatric history, discuss your treatment goals, and recommend a personalized plan. Contact us at (914) 241-0758 or visit our New Patients page to get started in Mt Kisco, NY.